USANA HEALTH SCIENCES INC
For the period ended Dec 28, 2024. Filed Mar 12, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 12, 2025
USNA$13.85+1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except par value)
| As ofDecember 28,2024 | As ofDecember 30,2023 | |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $181,768 | $330,420 |
| Inventories | 69,735 | 61,454 |
| Prepaid expenses and other current assets | 27,684 | 25,872 |
| Total current assets | 279,187 | 417,746 |
| Property and equipment, net | 94,565 | 99,814 |
| Goodwill | 144,168 | 17,102 |
| Intangible assets, net | 151,823 | 29,919 |
| Deferred tax assets | 19,644 | 13,284 |
| Other assets | 58,806 | 54,892 |
| Total assets | $748,193 | $632,757 |
| LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST, AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | $11,984 | $10,070 |
| Line of credit | 23,000 | 786 |
| Other current liabilities | 104,641 | 107,989 |
| Total current liabilities | 139,625 | 118,845 |
| Deferred tax liabilities | 4,073 | 4,552 |
| Other long-term liabilities | 18,163 | 12,158 |
| Total liabilities | 161,861 | 135,555 |
| Redeemable noncontrolling interest | 54,223 | — |
| Stockholders' equity | ||
| Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,064 as of December 28, 2024 and 19,130 as of December 30, 2023 | 19 | 19 |
| Additional paid-in capital | 75,816 | 65,661 |
| Retained earnings | 478,944 | 445,217 |
| Accumulated other comprehensive income (loss) | (22,670) | (13,695) |
| Total stockholders' equity attributable to USANA | 532,109 | 497,202 |
| Total liabilities, redeemable noncontrolling interest, and stockholders' equity | $748,193 | $632,757 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.